Published 2009 | Version v1
Publication

Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine reverse transcription inhibitor backbone

Additional details

Created:
April 14, 2023
Modified:
November 30, 2023